One of the mechanisms that minimize the aberrant cross-talk between cAMP-and cGMP-dependent signalling pathways relies on the selectivity of cAMP-binding domains (CBDs). For instance, the CBDs of the two critical eukaryotic cAMP receptors, i.e. protein kinase A (PKA) and the exchange protein activated by cAMP (EPAC), are both selectively activated by cAMP. However, the mechanisms underlying their cAMP vs. cGMP selectivity are quite distinct. In PKA this selectivity is controlled mainly at the level of ligand affinity, whereas in EPAC it is mostly determined at the level of allostery. Currently, the molecular basis for these different selectivity mechanisms is not fully understood. We have therefore comparatively analyzed by NMR the cGMP-bound states of the essential CBDs of PKA and EPAC, revealing key differences between them. Specifically, cGMP binds PKA preserving the same syn base orientation as cAMP at the price of local steric clashes, which lead to a reduced affinity for cGMP. Unlike PKA, cGMP is recognized by EPAC in an anti conformation and generates several short-and long-range perturbations. While these effects do not alter significantly the structure of the EPAC CBD investigated, remarkable differences in dynamics between the cAMP-and cGMP-bound states are detected for the ionic latch region. These observations suggest that one of the determinants of cGMP antagonism in EPAC is the modulation of the entropic control of inhibitory interactions and illustrate the pivotal role of allostery in determining signalling selectivity as a function of dynamic changes, even in the absence of significant affinity variations.
drug leads targeting the CBDs of either of these two eukaryotic protein systems requires an in depth analysis of how PKA and EPAC selectively recognize and allosterically respond to diverse cyclic nucleotide monophosphates (cNMPs). For instance, the cAMP and cGMP second messengers control distinct groups of essential signalling pathways (1) (2) (3) (4) (5) (6) . It is therefore critical to minimize the cross-talk between the cAMP-and cGMPdependent cellular responses. While in vivo the selective control of the cAMP-and/or cGMPdependent signaling pathways is a complex process which depends on multiple factors including the modulation of cNMP synthesis, degradation and compartmentalization (5) , one of the key mechanisms to reduce the cAMP / cGMP cross-talk relies on the ability of both PKA and EPAC CBDs to sense selectively cAMP as opposed to cGMP.
Despite the fact that both PKA and EPAC CBDs are cAMP-selective sensors, these two signalling systems adopt different mechanisms to implement their cAMP-selective response. Specifically, in the PKA system cGMP is an agonist of cAMP, i.e. cGMP is able to activate PKA once it binds the R subunit. However, the affinity of cGMP for the PKA R subunit is significantly lower than that of cAMP, resulting in an activation constant which is two orders of magnitude higher than that of cAMP (i.e. K a of 21 ± 2 nM for cAMP and of 4100 ± 20 nM for cGMP) (7, 8) . Unlike PKA, EPAC preserves ~PM affinities for both cAMP and cGMP, but in EPAC the latter cNMP is an antagonist of cAMP (9, 10) , i.e. cGMP, like other N6-substituted cAMP analogs, binds effectively to the CBD of EPAC but fails to fully activate its GEF activity (9, 10) .
The molecular basis for the cGMP antagonism selectively observed in EPAC but not in PKA is currently not fully understood. An initial hypothesis to explain the antagonist function of cGMP in EPAC has been recently proposed based on the structure of the ternary SpcAMPS:EPAC2 m :Rap1 complex (11) , which shows that the N 6 of the Sp-cAMPS agonist forms an hydrogen-bond with the backbone carbonyl oxygen of K450 located in the lid region (Table  S1 ) (11) . The disruption of this hydrogen-bond by cGMP has been hypothesised to result in the inhibition of EPAC activation (11) . However, a similar backbone hydrogen bond between the N 6 of cAMP and the backbone carbonyl oxygen of R632 has been observed also in the CBDs of the hyperpolarization-activated cyclic nucleotide modulated channels (HCN) (Table S1) , for which cGMP, like in PKA, is not an antagonist (12) . This observation suggests that the elimination of the cAMP N 6 hydrogen-bond alone may not be sufficient to fully explain why cGMP is a cAMP antagonist with respect to the activation of EPAC. Furthermore, the previously proposed hypothesis based on the simple disruption by cGMP of the N 6 hydrogen-bond does not consider the possibility that cGMP may adopt an EPAC-bound conformation different from that of cAMP and/or that cGMP may affect also the inhibitory interactions between the ionic latch (IL) residues of the EPAC RR and the CDC25HD catalytic domain. These RR/CR salt bridges stabilize the EPAC system in an overall 'closed' topology, whereby the RR sterically occludes access of Rap1 into the catalytic domain of EPAC (13) . cAMPbinding results in increased ps-ns and ms-Ps dynamics at the ionic latch region, which in turn leads to an increased entropic penalty for the inhibitory interactions mediated by the ionic latch (14) . In other words, cAMP is able to weaken the inhibitory interactions between the regulatory and catalytic regions of EPAC by increasing the entropic cost associated with the formation of the cluster of ionic latch salt bridges between these two functional segments. This dynamically driven mechanism contributes to the observed cAMPdependent shift towards active 'open' conformations of EPAC and we hypothesize that one of the effects of cGMP is to perturb the dynamic patterns of the EPAC CBD, thus altering the entropic control of the inhibitory interactions.
In order to test our hypotheses on cGMP agonism/antagonism and to further understand the molecular mechanisms underlying the different signalling responses of PKA and EPAC to the two endogenous second messengers cAMP and cGMP, here we present a comparative NMR analysis of cGMP-binding and allostery for the critical CBDs of both PKA and EPAC. These results were also compared to the data on the same domains in their apo and cAMP-bound states (14) (15) (16) (17) (18) (19) (20) . All these studies rely on the RID (119-244) and the related EPAC1 h (149-318) construct ( Fig. 1) , which have been previously validated as models of the essential CBDs of PKA and EPAC, respectively (14) (15) (16) (17) (18) (19) (20) .
Our comparative NMR analysis has revealed that the structure, dynamics and allosteric activation pathways of the PKA CBD-A are not significantly altered when cAMP is replaced by cGMP. However, significant differences between these two cNMPs are found for the EPAC1 h CBD at the level of both ligand recognition and modulation of dynamic modes, leading to a mechanism in which cGMP shifts the activation equilibrium of EPAC towards the auto-inhibited state, thus accounting for its antagonistic function.
EXPERIMENTAL PROCEDURES

Expression, Purification and NMR Sample Preparation of RID (119-244):
The regulatory subunit of PKA was expressed and purified as described before (15) (16) (17) (18) (19) . In brief, singly uniformly 15 N labeled samples were prepared by growing the bacteria in 15 NH 4 Cl containing M9 minimal media. The bacteria were grown at 37 o C before induction with 0.5 mM IPTG at a 0.8 OD 600nm for 20 hours at 22 o C. The cells were then lysed by three cycles of French press after resuspending them in the lysis buffer (20 mM MES pH 6.5, 100 mM NaCl, 2 mM EGTA, 2 mM EDTA and 5 mM DTT). The cell debris was removed by centrifugation and the protein was fractionated by a 40 % ammonium sulfate cut. The precipitant was again re-suspended with lysis buffer and incubated overnight with cAMP sepharose beads at 4 o C. The resins were then thoroughly washed with high salt buffer (lysis buffer containing 700 mM NaCl) before eluting the protein with 25 mM, 35 mM and 40 mM cAMP (Sigma). The protein was further purified through a Superdex S75 gel filtration column, which was pre-equilibrated with 50 mM MES pH 6.5, 100 mM NaCl. The cAMP sample was prepared by adding 1 mM cAMP and 5% D 2 O to the dilute sample and then concentrating to a protein concentration of 0.5 mM. The cGMPbound RID (119-244) sample was prepared by eluting with cGMP rather than cAMP.
The sample for the Nz exchange experiments was prepared following a previously explained denaturation/renaturation protocol (15, 16) . cAMP was removed by extensive dialysis in 8 M urea and the protein was refolded to its native conformation by a stepwise removal of urea. The correct refolding of the protein was validated by comparing the HSQC spectra of the original cAMP-bound and the refolded sample to which cAMP was re-added as a control. The 50:50 cAMP and cGMP sample was prepared by adding equal amounts of both ligands to the cAMP free protein. The   15   N and   13   C/   15 N labeled EPAC1 h (149-318) samples were expressed as GST-fusion proteins (11, 13, 14, 20) . The bacteria were induced with 1 mM IPTG at a 0.6 OD 600nm for 3 hours at 37 o C (14, 20) . The cells were then re-suspended in lysis buffer (PBS, 10 mM EDTA, 10 % v/v glycerol, supplemented with protease inhibitors) and lysed by French press. The supernatant obtained after removing the cell debris was incubated with GSH-sepharose beads at 4 o C for 4 hours. The beads were then thoroughly washed with wash buffer (0.5 M NaCl and 50 mM Tris pH 8). The GST tag was removed from EPAC by using biotinylated thrombin (NOVAGEN) for 16 hours at 4 o C followed by thrombin removal via Streptavidin beads. The protein was further purified through a Q column by using a 0-1M NaCl gradient in 50 mM Tris pH 7.6 buffer.
Expression, Purification and NMR Sample Preparation of EPAC1 h ̓ (149-318):
Finally the protein was dialyzed against the NMR buffer (50 mM Tris at pH 7.6 with Mes, 50 mM NaCl, 1 mM TCEP, 0.02 % w/v NaN 3 , 5 % v/v D 2 O) and concentrated to 0.5 mM, unless otherwise specified. To obtain cAMP-or cGMP-bound EPAC1 h (149-318), 2 mM cAMP or cGMP were added to the final purified apo rotein.
ing through the program Sparky3 p NMR Spectroscopy: All NMR spectra were acquired with a Bruker AV 700 spectrometer equipped with a TCI cryoprobe at 306 K. Unless otherwise mentioned, all spectra were recorded with 128 complex point and a 31. 8 , where ǻį 1H and ǻį 15N are the differences between the proton and nitrogen chemical shifts, respectively (27) . The chemical shift changes between the apo and the ligand bound states were calculated according to GZ = 0.2 g calculated as described above for RID (119-244).
ith a spectral width f 8389 Hz for both dimensions. 'G 15N + 'G 1H (28) . The assignment of cGMP-bound EPAC 1h (149-318) was obtained throu h standard triple resonance experiments (i.e. HNCO, HNCA, HN(CO)CA, CBCA(CO)NH and HNCACB), as previously explained (14, 20, 29) . The triple resonance data were analyzed through Sparky 3.111 (23) and the PECAN software was used to determine the probabilities of secondary structural elements by using the secondary chemical shifts (30) . Compounded chemical shifts between the cAMP-and cGMP-bound states of EPAC1 h (149-318) and the chemical shift changes between the apo and the ligand bound forms were Syn/Anti Base Orientation of Free cAMP and cGMP: 0.5 mM cAMP and cGMP solutions were prepared in a 100 % D 2 O buffer (20mM phosphate buffer pH 7.5 and 50 mM NaCl). To confirm the assignment of the cAMP and cGMP 1D 1 H spectra, 2D homo-nuclear ( 1 H-1 H) TOCSY spectra were acquired with spectral widths of 8389 Hz for both the directly and indirectly detected dimensions using 2048 and 512 complex points, respectively. The TOCSY spin-lock was set at 60 ms with a 10 kHz strength. The resonance of the adenine H8 proton was distinguished from that of the partially overlapped adenine H2 proton based on the 1D spectra of d 8 (33, 34) . Samples were prepared in a D 2 O solution composed of 20 mM phosphate buffer at pH 7.5 and 50 mM NaCl. The spectra were measured with 2048 and 420 complex points and spectral widths of 8389 × 8389 Hz, respectively. The NOE mixing time was set at 80 ms. Cross-peaks arising from cross-relaxation were differentiated from exchange peaks by a 2D-ROESY experiment (35) recorded with a spectral width of 11 ppm for both dimensions and with 1K and 200 complex points, respectively. The ROESY mixing time was set a 1
H/D Exchange Experiments:
Amide proton H/D exchange rates were determined from the cross-peak intensities in a series of 15 N HSQC spectra acquired as function of time. The cGMPbound RID (119-244) was exchanged to D 2 O by passing it through a gel filtration column preequilibrated with a 100 % D 2 O buffer (1 mM cGMP, 50 mM MES pH 6.5, 100 mM NaCl), as previously described (15) . cGMP-and cAMPbound EPAC 1h (149-318) were exchanged to D 2 O by 10-fold dilution in a 100 % D 2 O buffer (2 mM cGMP or cAMP, 50 mM Tris pH 7.6, 50 mM NaCl, 1 mM TCEP). The apo EPAC sample was exchanged with D 2 O in a 100 % D 2 O buffer without cGMP or cAMP. A total of 84 HSQC spectra were acquired. For the first 30 spectra 2 scans were acquired, while the rest of the spectra were recorded with 4 scan. The time between the first exposure to D 2 O and the first HSQC spectra (dead time) was ~20 min. The intensities of the slowly exchanging amide peaks were monitored for several days after exposure to D 2 O. The HSQC cross peak intensities were analyzed using NMRPipe (21) and the exchange rates were determined by using the Curvefit software by implementing Levenberg-Marqardt non-linear least square exponential fitting (36) . The protection factors were calculated using the ratio of intrinsic exchange rates (computed based on poly alanine through the program SPHERE (37)) to the experimental HD exchange rates, assuming an EX2 exchanging mechanism as previously explained (15 (41) . The entire series of R 1 and R 2 relaxation rates were collected in triplicate and the NOE spectra were collected as a set of ten replicas. The acquired spectra were then co-added in the time domain prior to Fourier transformation. The R 1 and R 2 relaxation rates were determined by using the program Sparky (23) using the crosspeak fit heights. The errors on the R 1 and R 2 rates were estimated from the Gaussian distributed random noise. The error on the NOE values were gauged based on the standard deviation between fit heights in the replicate spectra. The effects of diffusional anisotropy and the overall tumbling of the protein on the relaxation rates and the reduced spectral densities were evaluated as described previously by using the HYDRONMR program (14, 42, 43) . the easured N relaxation rates and { H}-{ N} OE data.
xperimental distances measure
Reduced Spectral Density Analyses: The R 1 and R 2 relaxation rates and hetero-nuclear steady state { 1 H}-{ 15 N} NOEs were analyzed by reduced spectral density mapping (44, 45) , under the assumption that the spectral density functions at high frequency are equal: N} NOE data (44, 45) . Errors on the reduced spectral density were evaluated from the propagation of the uncertainties in 15 1 15 m N
RESULTS
Syn / Anti Base Orientations in Free and Bound cAMP.
Analysis of the structures previously solved for different cyclic nucleotidebound CBDs (Table S1 ) reveals that these ligands can dock either in a syn or in an anti conformation (11, 12, (46) (47) (48) (49) . For instance, cAMP binds both CBDs of PKA in a syn conformation, as previously shown by X-ray crystallography (46) , while the same cNMP docks into the CBDs of cyclic nucleotide-gated ion channels in an anti orientation (48) . The syn and anti conformations differ mainly for the orientation of the aromatic base with respect to the ribose moiety. In syn cNMPs the base is rotated over the ribose ring, while in anti cNMPs the base is rotated away from the ribose ring. Using the bound-cNMPs structures listed in Table S1 (11, 12, (46) (47) (48) (49) , it is possible to evaluate for both syn and anti conformations the expected distance ranges between NMR detectable protons, such as the H1', H2', H2 and H8 atoms of cAMP ( Fig. S1 ), as summarized in Table S2 . Table S2 shows that, as expected, the H1'-H2' distance does not change significantly with the change in orientation of the nucleotide base and therefore this distance was selected as a reference in syn vs. anti comparisons. Table S2 also reveals that the syn and the anti conformations differ for the relative distances between H8 and the ribose protons, indicating that the NOEs involving H8 are sufficient to probe the orientation of the adenine base. For instance, in the syn conformation the H8-H1` distance is significantly shorter than that in the anti conformation (Table S2) , whereas the distance between H8-H3` is longer in the syn conformation relative to the anti orientation (Table  S2) . Therefore, we expect for the syn conformation a strong NOE signal between H8 and H1` along with a weak or absent NOE signal between H8 and H3`. On the other hand, the anti conformation will give rise to a medium NOE signal between H8 and H1` and a stronger NOE signal between H8 and H3`.
These NOE 'signatures' for the syn and anti conformations were used to interpret the e d for free and bound cyclic nucleotides ( Fig. 2 and Supp. Material).
The normalized NOE and ROE intensities measured for EPAC-bound and for free cAMP are summarized in Tables 1 and 2 , respectively. For free cAMP, a medium NOE signal between H8-H1` was observed (Table 2) , which is consistent with a predominantly anti conformation, as also supported by the weak NOE detected between the H2 and H1' protons ( Table 2, Table S2 ). However, the strong H8-H1` NOE signal observed for EPAC-bound cAMP (Table 1) suggests that cAMP binds to EPAC in a syn conformation, as also confirmed by the absence of the H2-H1' NOE ( Table 1, Table S2 ). This result is also independently confirmed by the syn conformation determined for Sp-cAMPS in the recently published Sp-cAMPS:EPAC2 m :RAP ternary complex (11) , validating the effectiveness of our NOE based approach for distinguishing between syn and ) (47) . The conclusions of these syn / anti conformational analyse between the cAMP-bound and the cGMP-bound gression outliers in Fig.  3a , c an the purpose of assessin to the structure of the ID CBD-A.
anti orientations.
Syn / Anti Base Orientations in Free and
Bound cGMP. The NOE method was then extended to free and EPAC-bound cGMP, for which no previous structural information is available (Tables 1, 2 and S2). The strong H8-H1` NOE observed for free cGMP ( Fig. 2c and Table  2 ) suggests that cGMP exists predominantly in a syn conformation in solution. However, the medium H8-H1` NOE and the strong H8-H3` NOE measured for EPAC-bound cGMP (Fig 3d and Table 1 ) indicate that upon binding to EPAC1 h (149-318) there is an equilibrium shift, whereby the state with the highest population corresponds to cGMP in an anti conformation. This result defines a distinct difference between cGMP bound to EPAC and to PKA, as in the latter X-ray crystallography has shown that cGMP prefers a syn conformation (Table S1 s are summarized in Table 3 .
Comparative Analysis of the PKA CBD-A Structure in the cAMP-and cGMP-Bound States.
The magnitude of the structural differences between the cAMP-and cGMP-bound states of RID (119-244) was evaluated through the comparative analysis of the amide chemical shifts, which were assigned as explained in the Supp. Material section.
Specifically, the cGMPdependent amide chemical shift variations were correlated with the corresponding ppm changes caused by cAMP binding, as shown in Fig. 3a -e. The all-residue correlation (Fig. 3a) results in a slope close to one (i.e. 1.01) and an R value of 0.97. Similar results were obtained through subdomain specific linear regressions (Fig. 3b-e) , which preserve a high degree of correlation states. The strong correlation between these two states suggests that cGMP-bound RID (119-244) is structurally very similar to the cAMP-bound state. However, while the linearity of these correlations (Fig. 3a-e) supports the absence of significant global conformational changes when cAMP is replaced by cGMP, a local perturbation is detected at the level of two adjacent residues located C-terminal to the phosphate binding cassette (PBC), i.e. A211 and T212, which consistently appear as re d d. Our chemical-shift based assessment of the similarity between the cAMP-and cGMPbound states of RID is independently validated by the crystal structures of RID in complex with cAMP and cGMP (PDB codes: 1RGS and 1RL3, respectively) (46, 47), which reveal a high level of structural homology with a backbone-to-backbone RMSD of only ~0.4 Å. Furthermore, these crystal structures unveiled a slight cGMP-specific distortion at the C-terminus of the PBC, which is in full agreement with the A211 and T212 outliers detected in the correlations of Fig. 3a, c, d , providing further confirmation of the validity of our chemical shift regressions for g structural perturbations.
The binding of cGMP to RID (119-144) was also mapped through compounded chemical shifts (Fig. 4a) .
Unlike the chemical shift correlations discussed above (Fig. 3) , the compounded chemical shift difference maps of Fig. 4 compare directly the cAMP-bound and cGMP-bound states without biases from the chemical shifts of the apo state and therefore provide a clearer picture of local perturbations linked to ligand changes. This is particularly important for residues which are unassigned in the apo state due, for instance, to line-broadening beyond detection, as in the case of A210 in RID (119-244). Such residues cannot be included in the apo vs. cNMP correlations of Fig. 3 , but are present in Fig. 4 . Specifically, Fig. 4a reveals that cGMP induces only local chemical shift changes confined mainly to the E4 strand, in the base binding region (BBR), and to the PBC termini, i.e. G199 at the N-terminus of the PBC and A210, A211 and T212, at the C-terminus of the PBC, as also shown in Fig. 4c , which maps these cGMPdependent perturbations in R
Comparative Analysis of the EPAC1 CBD Structure in the cAMP-and cGMP-Bound States.
The linear correlation analysis approach was also used to evaluate cAMP vs. cGMP structural differences for EPAC1 h (149-318) (Fig. 3f-l) , for which no cGMP-bound structure has been solved yet. Again, the strong correlations observed in the plots of Fig. 3f -l, as evident from the slope and R values close to unity, suggest that the binding of cGMP induces similar global structural rearrangements as that of cAMP. However, a close inspection of the chemical shift variations in EPAC1 h (149-318) (Fig. 3 h-k) reveals several outliers indicative of local structural differences between the cGMP-and cAMP-bound structures. For instance, H206 in D3 within the N-terminal helical-bundle (NTHB) (Fig. 3h, j) , V259 in the base binding region (BBR) and the PBC residues G269, A280, A281 and T282 display significant chemical shift variations as cAMP is replaced by cGMP (Fig. 3h, i, k) . Despite the presence of these multiple local perturbations involving D3 and the cAMP binding site, interestingly the D6 helix and the ionic latch region (i.e. in the Nterminal helical-bundle did not exhibit any significant structural change upon substitution of cAMP with cGMP ( Fig. 3 h-l) , as also independently supported by the 2 o structure analysis (Fig. S2 ) based on the secondary chemical shifts. Specifically, the secondary structure comparison between the apo, the cAMP-and the cGMP-bound states of EPAC1 h (149-318) (Fig.  S2) indicates that, similarly to cAMP, binding of cGMP significantly destabilizes the C-terminal region of the D6 hinge helix (Fig. S2b,c) .
As for our analysis of the PKA system, the effect of cGMP on the structure of EPAC1 h (149-318) was mapped also by compounded chemical shift changes (Fig. 4b, d) . Fig. 4b,d consistently shows that, unlike in PKA, in EPAC the substitution of cAMP with cGMP causes perturbations that propagate well beyond the PBC termini and the BBR E4. Specifically, panels b and d of Fig. 4 indicate that the binding of cGMP also affects the other strand of the base binding region (BBR) (i.e. E5) as well as H206 in D3, within the N-terminal helical-bundle, and residues in the D5 region of the PBC (i.e. A272 and V274).
Comparative Analysis of the PKA CBD-A Solvent Protection in the cAMP-and cGMPBound States. Chemical shifts probe mainly the most stable structures accessible to proteins and may not sense ligand-dependent perturbations at the level of partially unfolded excited states, which are however detected through variations in HD exchange rates and in the corresponding protection factors (PFs), as shown in Fig. 5a for cGMPbound RID (119-244). The resulting cGMPdependent changes in PFs are mapped into the structure of the RID CBD-A in Fig. 6a . The HD exchange data in Fig. 5a and Fig 6a show (20) , display in the cGMP-bound state intermediate values between those measured for the apo and cAMPbound states. Interestingly, the ''G unfolding (1.65 ± 0.70 kcal/mol) calculated based on the average PF max for the E-subdomain of the cGMP-bound state (i.e. <PF max > E = 5.47 ± 'G unfolding = ± kcal/mol and of the cAMP-bound state (i.e. <PF max > E = 6.66 ± 'G unfolding = ± kcal/mol agrees well with the ''G unfolding of 1.5 kcal/mol calculated based on the dissociation constants of cGMP and cAMP for this domain (50) , as explained in the Supp. Material section. This observation indicates that the observed reduction in the maximal PFs occurring as cAMP is replaced by cGMP is mainly due to the reduced binding ability of cGMP compared to cAMP. However, replacement of the adenine of cAMP with the guanine of cGMP does not significantly affect regions outside the Esubdomain, which are subject mainly to local rather than global transient unfolding events. For instance, the PFs measured for the N-and Cterminal helices of RID (119-244) remain largely unperturbed going from cAMP to cGMP (Fig. 5a ).
Comparative Analysis of the EPAC1 CBD Solvent Protection in the cAMP-and cGMPBound States. The HD PFs for EPAC1h (149-318) are reported in Figs. 5b and 6b. These data indicate that in the cGMP-bound state the protection of the A272 NH in the PBC is significantly lower than that observed for the cAMP-bound state (Fig. 5b and Fig. 6b ). Another striking feature of the EPAC1 h (149-318) PFs shown in Fig. 5b and Fig. 6b is that several residues in D1 and D2 are more protected in the cGMP-bound state than in the cAMP-bound state, suggesting that these helices are at least partially stabilized when cAMP is replaced by cGMP. Unlike D1 and D2, binding of cGMP causes a distinct reduction in several PFs measured for the helices adjacent to the E-barrel (i.e. D4 and D6) and for the E-subdomain. For instance, L207 and R213 in D4 and F300, I303 and I304 in D6 all become fast exchanging upon cGMP-binding (i.e. they exchange within the dead time of the HD experiment or by the second HSQC after exposure to D 2 O) similarly to the apo state (Fig. 5b, Fig.  6b ). Similar transitions from protected amides in the cAMP-bound state to fast exchanging residues in the cGMP-bound state are also observed for two clusters of adjacent residues in the E-subdomain (Fig. 6c, d ). One cluster is formed by W245 and K246 in E3 and G265 in the neighbouring E6 strand (Fig. 6d) , while another cluster includes R279 at the C-terminus of the PBC as well as S233 and D236 in the adjacent E2-3 loop (Fig. 6c) . The remaining cGMP-dependent changes in the maximal protection factors (Fig. 6b ) observed for the highly buried E-strands are consistent with the K D values previously reported for cGMP binding to EPAC (9) .
Overall, our HD exchange data indicate, consistently with our compounded chemical shift results, that in EPAC, unlike in PKA, replacement of cAMP with cGMP induces long-range effects which propagate well beyond the PBC into the Dand E-subdomains. In order to further explore the nature of these long-range perturbations, we have extended our comparative NMR investigations to HSQC line-width analyses and to 15 N relaxation measurements, designed to probe dynamics in the ps-ns and ms-Ps time-scales.
Comparative Analysis of the PKA CBD-A Dynamics in the cAMP-and cGMP-Bound States.
The changes in dynamics in RID (119-244) occurring as cAMP is replaced by cGMP were probed through line-width analyses. The differential line broadening of HSQC cross-peaks between the two bound-states is sensitive to ps-ns and ms-Ps backbone dynamics (14, 22) . For instance, ms-Ps chemical exchange significantly broadens the line width resulting in a decreased HSQC cross-peak intensity, whereas the presence of fast (ps-ns) motions will sharpen the peaks leading to an increased HSQC cross-peak intensity. We therefore analyzed the correlation between the normalized HSQC cross-peak intensities in the cAMP-and in the cGMP-bound states of RID (119-244) (Fig. 7a) . The intensities of the HSQC spectra of RID (119-244) are normalized against Y244 (Fig. 7a) , because this Cterminal residue has the highest intensity in both ligand bound forms and its intensity is independent of ligand binding. The relatively high correlation coefficient (0.94) observed between the cGMP-and cAMP-bound states of RID (119-244) (Fig. 7a) suggests that the binding of cGMP does not induce any significant line broadening or change in dynamics for this CBD of PKA. Due to the similarity between the cAMP-bound and cGMP-bound dynamic patterns observed for PKA we did not investigate further the dynamics of cGMP-bound PKA.
Comparative Analysis of the EPAC1 CBD Dynamics in the cAMP-and cGMP-Bound States.
Similarly to PKA, the changes in dynamics in EPAC1 CBD occurring as cAMP is replaced by cGMP were initially assessed through the correlation between the normalized HSQC crosspeak intensities in the cAMP-and in the cGMPbound states of EPAC1 h (149-318) (Fig. 7b) . In Fig. 7b the HSQC intensities are normalized against L159, because L159 has the highest intensity in both ligand bound forms and its intensity is independent of ligand binding. Fig. 7b shows that, unlike PKA, for EPAC1 h (149-318) a poor correlation (R = 0.65) is observed between the differential line broadenings of the cGMP-and cAMP-bound states suggesting that the binding of cGMP significantly perturbs the dynamics of EPAC. This conclusion is also supported by the presence of multiple outliers in the correlation shown in Fig. 7b .
In order to understand how cGMP binding affects the dynamic patterns of the different subdomains of EPAC, we further probed the ps-ns and Ps-ms dynamics of cGMP-bound EPAC1 h (149-318) through the measurement of 15 N longitudinal (R 1 ), transverse (R 2 ) relaxation rates and of hetero-nuclear { 1 H}- 15 N NOEs (Fig. 8a, b,  d) , and compared our results with those previously reported for the apo and cAMP-bound states of the same EPAC domain (14) . The relaxation data were also analysed through reduced spectral density mapping (Fig. 9a-c) . The cGMPdependent changes in dynamics relative to the cAMP-bound state revealed by our 15 N relaxation experiments ( Fig. 8 and Fig. 9 ) were then mapped into the 3D structures of EPAC in Fig. 10a,b and Fig. 10c,d for the ps-ns and ms-Ps time-scales, respectively. The maps of Fig. 10 reveal that cGMP modulates the dynamics of the EPAC CBD at multiple sites affecting both the E-and Dsubdomains.
One of the most striking features revealed by the relaxation data recorded for cGMP-bound EPAC 1h (149-318) (Figs. 8-10 ) is a quenching of dynamics at several critical locations in the Nterminal helical-bundle. For instance, cGMPbinding results in quenching of ms-Ps and/or ps-ns dynamics for several residues in the ionic latch region (i.e. R169, G170, D172, A173, L174, L175 and E197), as evident from the R 1 R 2 , J(0), NOE and J(Z H + Z N ) values. This result is confirmed also by the statistical analysis of the relaxation rates shown in Table 4 , which reveals that for the ionic latch residues the average R 1 R 2 value observed in the cGMP-bound state is significantly closer to that of the apo form than to that of the cAMP-bound state. A similar pattern was also observed for the cGMP-dependence of the NOE and J(Z H + Z N ) averages over the ionic latch region ( Table 4 ). The statistical analysis of Table  4 therefore confirms that cGMP consistently quenches the dynamics of the ionic latch region in both the ps-ns and the ms-Ps time-scales, bringing the relaxation rates and corresponding spectral densities to values comparable to those previously reported for the inactive apo state (14) .
The consistent quenching of both ps-ns and ms-Ps dynamics to values closer to those of the inactive state as cAMP is replaced by cGMP is a feature that is quite unique of the ionic latch site. Indeed other regions, such as for instance the D3 helix, display a mixed pattern in which cGMP quenches the ms-Ps dynamics but enhances the psns flexibility relative to the cAMP-bound state (Table 4 ). In addition, cGMP-binding quenches relatively to cAMP the ms-Ps dynamics of Q234 at the E2-E3 loop, E6 (D267 and F268) and E8 (L293, R294 and D296). On the other hand, the NOE data and J(Z H +Z N ) values indicate that upon substituting cAMP with cGMP an increase in psns dynamics occurs for F232 and D236 at the E2-E3 region, K246 at the E4, G265 at the Nterminus of E6 and L271 at the N-terminus of PBC (Figs. 8-10) . A mixed pattern of cGMP-dependent dynamic changes is observed also for D6 (Figs. 8-10 ). However, for this C-terminal region the average R 1 R 2 and J(0) values (Table 4) reveal that there is still a net enhancement in ms-Ps dynamics in the cGMP-bound form relative to the apo state, as also previously observed for the cAMP-bound state (14) .
DISCUSSION
Binding of cAMP to PKA Is Coupled with an Anti to Syn Transition. The CBDs of the Rsubunit of PKA bind cAMP in a syn conformation (46) , while our data indicate a predominantly anti orientation for cAMP free in solution (Table 3 ). These observations suggest that the binding of cAMP to PKA is coupled with an anti to syn transition, most likely driven by several hydrophobic and stacking interactions between the adenine base of cAMP and the PKA CBDs (Table  S1 ).
Binding of cGMP to PKA Does Not Require an Anti to Syn Transition but Introduces Short-Range Perturbations Confined to the Cyclic
Nucleotide Binding Site. Unlike cAMP, cGMP free in solution prefers a syn conformation and it preserves this base orientation even after binding PKA (47) . The syn structure of PKA-bound cGMP ensures that the guanine base can interact with the same hydrophobic and aromatic residues that drive the binding of syn cAMP (Table S1 ) (46) . However, the binding of syn cGMP to PKA introduces steric clashes between the N 2 H2 of cGMP and the CE of A210, which result in a slight distortion of the C-terminus of the PBC relative to the cAMP-bound structure, as shown before by crystallography (47) . This structural perturbation is also confirmed by our chemical shift (Fig.  3a,c,d, Fig. 4a,c) and HD (Fig. 5a, Fig. 6a ) maps on RID (119-244), showing that the hydrogenbond between the A210 NH and the axial exocyclic phosphate oxygen is significantly weakened as cAMP is replaced by cGMP. In addition, our NMR data also show that the distortion of the PBC C-terminus caused by cGMP propagates to the N-terminus of the PBC and to the BBR (Fig. 4a,c, Fig. 5a, Fig. 6a) . Specifically, the hydrogen-bond between the G199 NH and the 2'-OH of the ribose becomes weaker as cAMP is replaced by cGMP and the local environment of N185 in the BBR is perturbed. -244) caused by the replacement of cAMP with cGMP and confined to the PBC termini and the BBR are reminiscent of the effects previously reported (16) for the phosphorothioate Sp-cAMPS analog. The Sp-cAMPS ligand is a cAMP agonist where the axial exocyclic phosphate oxygen hydrogenbonded to A210 is isolobally replaced by a bulky sulphur atom. For both cGMP and Sp-cAMPS the steric hindrance at the C-terminus of the PBC results in reduced binding affinities compared to cAMP (9) . Furthermore, for both cGMP and SpcAMPS the distortion of A210 is propagated through the adjacent Q165 to N185 (16) . N185 is located in the hyper-variable E4-E5 loop, which is known to be subject to high sequence variability among different cAMP-binding domains (51) and it is not considered critical for the allosteric activation of PKA. Furthermore, no significant cGMP-dependent perturbations relative to the cAMP-bound form are observed for regions known to be essential 'hot-spots' of the allosteric network of PKA (i.e. the D-B' helix in the PBC, the hinge D-B/C helix, G169 and D170 in the E2-3 loop) (15, 16, 52, 53) . In addition, the dynamic profile of cGMP-bound RID (119-244) does not differ significantly from that of cAMP-bound RID (119-244) (Fig. 7a) , suggesting that also the entropic determinants of the allosteric control of PKA are preserved by cGMP.
Overall, it appears therefore that, similarly to Sp-cAMPS, the perturbations on RID caused by cGMP relative to the cAMP-bound state are limited to recognition rather than allosteric effects, explaining why both Sp-cAMPS and cGMP act as weak agonists of cAMP with respect to the activation of PKA. In other words, our data explain why the cAMP vs. cGMP second messenger selectivity of PKA is controlled primarily at the level of binding affinity rather than allostery.
Binding of cAMP to EPAC Is Coupled with an Anti to Syn Transition.
Similarly to PKA, the essential CBD of EPAC recognizes cAMP in a syn conformation as shown by our NMR data for EPAC1 h (149-318) bound to cAMP and also by crystallography for the longer EPAC 2m '305 construct bound to the agonist Sp-cAMPS and Rap1B (11) . These observations indicate that cAMP binding is coupled to an anti to syn transition for both PKA and EPAC. However, the nature of the CBD-base interactions is quite different in these two systems. In PKA the adenine of cAMP interacts primarily with hydrophobic and aromatic residues in both CBDs without requiring the N 6 H 2 group of the adenine (Table S1 ) (46) . Unlike PKA, in EPAC the adenine base is involved in both hydrophobic and hydrophilic interactions (Table S1) , including an adeninespecific hydrogen bond with the N 6 H 2 of cAMP (11) .
Binding of cGMP to EPAC Is Coupled with a Syn to Anti Transition. As a result of the adenine specific interactions in EPAC mentioned above, when cAMP is substituted with cGMP the hydrogen bond involving the N 6 H 2 is lost and the base is now free to change orientation from syn to anti in order to release the steric hindrance between the N 2 H 2 of the guanine and the CE of the conserved Alanine at the C-terminus of the PBC (i.e. A280 in EPAC1 h and A415 in EPAC2 m ) (Fig.  1c) .
Indeed, our NMR data support an anti conformation for EPAC-bound cGMP ( Fig. 2d and Tables 1 and 3 ), confirming that binding of cGMP to EPAC is coupled with a syn to anti transition, i.e. the reverse of the base re-orientation observed for cAMP binding to both PKA and EPAC (Table  3) .
The anti conformation adopted by cGMP when docked into the binding site of EPAC is also confirmed by the significant chemical shift changes observed for the base binding region (BBR) (i.e. E4 and E5) when cAMP-bound and cGMP-bound EPAC1 h (149-318) are compared ( Fig. 3h,i; Fig. 4b,d ). These changes reflect an overall decreased protection of the BBR in the cGMP-bound state relative to the cAMP-bound form, as indicated by our comparative HD analysis ( Fig. 5b; Fig. 6b ). Our chemical shift and HD perturbation maps (Fig. 3f-i,k; Fig. 4b,d; Fig. 5b ; Fig. 6b ) also show that the effects of the replacement of cAMP with cGMP in EPAC1 h (149-318) are not limited to the BBR, but they extend to most of the remaining parts of the cNMP binding site, i.e. the N-and C-termini of the PBC as well as its short D5 helix, suggesting that the docking of the cyclic phosphate and ribose moieties of cGMP into the EPAC CBD may differ at least slightly from that of cAMP.
cAMP vs. cGMP Selectivity Determinants in EPAC1.
Another major difference between the PKA and EPAC CBDs is that in the latter the perturbations caused by cGMP propagate well beyond the cNMP binding site (Supp. Material).
However, our cAMP vs. cGMP comparative NMR analyses reveal that the cGMP-dependent perturbations at the cNMP binding site and beyond do not significantly compromise the overall structural integrity of cAMP-bound EPAC1 h (149-318) and most remarkably preserve the conformational features of this CBD that are known to be pivotal for allosteric activation (i.e. D5 stabilization, D6 C-terminus destabilization and local environment of G238) (14, 20, 54) .
Despite of the structural similarities between the cAMP-bound and cGMP-bound states of the EPAC CBD, a critical difference is observed between cAMP and cGMP at the level of dynamic profiles measured for their complexes with EPAC1 h (149-318) . Specifically, the most striking effect of the replacement of cAMP with cGMP is a quenching of the ps-ns and ms-Ps dynamics for several residues in the N-terminal helical-bundle D1-2 ionic latch region ( Fig. 10 ; Table 4 ), which is involved in the inhibitory RR-CR interactions stabilizing the apo state. Consistently with the decreased ionic latch flexibility of the cGMP-bound state, multiple sites within helices D1-2 become more protected when cGMP replaces cAMP, in sharp contrast with the concurrent destabilization observed for the rest of the domain ( Fig. 5b; Fig. 6b) .
The decreased solvent exposure and the suppression of ps-ns and ms-Ps dynamics observed in the D1-D2 ionic latch region when cAMP is substituted with cGMP suggest that one of the determinants of the cGMP antagonism in EPAC is the reduction of the entropic penalty, which is otherwise used by cAMP to weaken and release the inhibitory ionic latch interactions (14) . Such a dynamically-driven allosteric mechanism promotes the selective response of EPAC systems to cAMP as opposed to cGMP and it may play a key role for the in vivo reduction of the cross-talk between cAMP-and cGMP-dependent signaling cascades. While it is clear that in vivo the selective activation of cAMP-and/or cGMPdependent pathways is also controlled through modulations in cNMP synthesis, degradation and compartmentalization (5), our results indicate that dynamically-driven allostery (14, (55) (56) (57) provides an additional level of control for the cNMP second-messenger selectivity.
CONCLUSIONS
The CBDs of both PKA and EPAC selectively sense the signal of cAMP rather than that of other second messengers such as cGMP. However, the mechanisms underlying these selective CBD responses to cAMP are remarkably different in these two systems. In PKA the cAMP vs. cGMP selectivity has evolved mainly at the level of binding affinity, whereas in EPAC the cNMP selectivity is mostly defined at the level of allosteric propagations. Our comparative NMR analyses of the structural and dynamic features of the PKA and EPAC CBDs in their cGMP-bound states have provided the molecular basis for the different selectivity mechanisms of these two critical eukaryotic signaling cNMP sensors. Specifically, the PKA CBD responds to cGMP similarly to a previously characterized cAMP agonist, i.e. Sp-cAMPS, whereby the same syn base orientation of cAMP is preserved at the price of steric clashes between the NH 2 in position 2 of the guanine and the C-terminus of the PBC. This hindrance causes a structural distortion in the Cterminal region of the PBC, which accounts for the reduced affinity for PKA. However the allosteric network of this CBD is not compromised by cGMP, as the only significant cGMP-specific effect that goes beyond the PBC is confined to the hyper-variable E4-5 loop, which has not been shown to be critical for the activation of PKA.
In contrast to PKA, cGMP in EPAC is recognized in an anti conformation and causes multiple perturbations in the cNMP binding site and beyond relative to the cAMP-bound form. While these cGMP-dependent effects do not significantly modify the structural features of the cAMP-bound EPAC1 CBD investigated, a remarkable difference is observed between the cAMP-and cGMP-bound states of the EPAC1 CBD at the level of the dynamic profile of the inhibitory ionic latch region. These observations suggest that in EPAC, unlike PKA, a key determinant of the selective response to cAMP is the differential dynamics at critical functional residues. Our study therefore highlights the evolution of allosteric mechanisms for determining signaling selectivity as a function of dynamic changes, even in the absence of significant differences in structure and in ligand affinities. Furthermore, the models of cNMP selectivity outlined here are anticipated to facilitate the design of future drug leads targeting cAMP-dependent pathways. (28) . The vertical axes report the differences in chemical shifts between the cGMP-bound and the apo states calculated using the same equation (28) . In panels (a) and (f) all the assigned CBD residues were used in the linear correlations, whereas in the other panels the correlations were confined to subsets of residues in order to better identify possible outliers. Specifically, (b) and (j) are for the N-terminal helical-bundle, (c), (g) and (i) for the Esubdomain (including the PBC), (d) and (k) for the PBC and (e) and (l) for the B/C helix. Due to the dominant chemical shift changes observed for A280 of EPAC 1h (149-318), the correlations of panels (f) and (g) were recalculated in panels (h) and (i), respectively, without A280. Similarly, the correlation for the N-terminal helical-bundle region in panel (j) was calculated excluding H206. The filled circles at the baseline refer to the fast exchanging residues within the dead time (20 min) of the experiment or by the first or second HSQCs. The residues affected by overlap are denoted as squares and the residues for which no data are reported are either ambiguous or proline. The backbone amides which exchange in the cGMP-bound state faster than the cAMP-bound state are highlighted with a pink background, whereas the residues exchanging more slowly relative to the cAMP-bound state are highlighted in blue. The secondary structures are denoted by the dotted line as explained in Fig. 4 . H} NOE calculated as I sat /I nonsat . In panels c and d, residues experiencing quenching or enhancement of dynamics upon cGMP binding relative to the cAMP-bound state of EPAC 1h (149-318) are highlighted with blue and red, respectively. In all panels, the rates calculated based on hydrodynamic bead models of EPAC1 h (149-309), (161-309) and (173-309), respectively are represented by pink horizontal lines, as previously described (14) . These values provide an assessment of the contribution to each rate from overall tumbling. The secondary structure is also shown in panel c similarly to Fig. 4 . The residues for which an apparent quenching in ms-Ps relaxation dynamics maybe also due to concurrently enhanced ps-ns relaxation rates are highlighted in blue dashed lines. Residues for which no relaxation data are available are prolines or are overlapped and/or broadened beyond detection. Fig. 8 (14) . In all the panels the residues showing enhanced or reduced dynamics upon cGMP-binding relative to the cAMP-bound state are highlighted in red and blue, respectively. Fig. 10 . Changes in ps -ns (a, b) and ms-Ps (c, d) dynamics for cGMP-bound EPAC 1h (149-318) relative to the cAMP-bound state are mapped onto the holo EPAC2 m structure (PDB 3CF6) (11) . Panels b and d were obtained from panels a and c, respectively, through a 180 o rotation. The residues experiencing quenching or enhancement in dynamics upon replacement of cAMP with cGMP are colored according to the color coding of Fig. 8 . The amino acid residues are labeled according to the sequence of EPAC1 h . The residues reported within brackets correspond to EPAC2 m and they are not conserved between EPAC1 h and EPAC2 m . Panel (e) shows the putative interactions between Q270 in the PBC, the 308, 310 residues and the N-terminal helical-bundle (i.e. D3). 
